STEERING COMMITTEE MEETING

Slides:



Advertisements
Similar presentations
High Resolution studies
Advertisements

High Resolution Italian studies Pamela Minicozzi Descriptive Studies and Health Planning Unit, Department of Preventive and Predictive Medicine, Fondazione.
Current status of EHES Kari Kuulasmaa EHES meeting Luxembourg, 2 March 2011.
Health in Prisons Project Establishing a Monitoring Mechanism on Prison Health Indicators and Health Determinants Working Party on Information on Lifestyle.
Task Force on Major and Chronic Diseases The Netherlands Institute for Health Services Research Project output related to ECHI Indicator lists December.
The EU I2010 benchmarking framework and its implementation GENEVE 29 June 2008.
EUROCHIP-3: WP-4 Publications Paolo Baili Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
High Resolution data for rare cancers Annalisa Trama Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy ) WORKSHOP FOR A EUROPEAN HIGH RESOLUTION.
Dr Andrea Micheli Descriptive Epidemiology and Health Planning Unit Fondazione IRCCS “Istituto Nazionale dei Tumori” Milan Public Health Programme EUROPEAN.
FROM EUROCHIP-1 TO EUROCHIP-2 EUROCHIP-2 - The action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.
Public Health Programme EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL EUROCHIP-3 WP-4 Update EUROCHIP: EUROpean Cancer Health Indicator.
European Partnership for Action Against Cancer (EPAAC)
THE EUROCHIP PROJECTS Health Indicators for Health Indicators for Monitoring Cancer in Europe
EUROCHIP-2 the action Health Indicators for Monitoring Cancer in Europe Public Health Program EUROPEAN.
EUROCHIP - EUROpean Cancer Health Indicators Project A fight against disequalities in managing cancer HMP HMP: Health Monitoring Programme Andrea Micheli.
Cancer inequalities in Europe UKACR & NCIN Conference, 17/18 June 2010 Dr. Andrea Micheli Director Descriptive Study and Health Planning Unit Fondazione.
Cancer inequalities in Europe Kielce, Polish conference on cancer, 13/15 June 2011 Dr. Andrea Micheli Director Descriptive Study and Health Planning Unit.
Keith Comiskey, Department of Health.  CANCON – European Guide on Quality Improvement in Comprehensive Cancer Control  Runs from Feb 2014 to Feb 2017.
Renee Otter WP5 leader. Health Strategies in Europe. Lisbon, July Coleman M.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Cervical Cancer - UK December 2011 For more information.
EUROCHIP - EUROpean Cancer Health Indicators Project A project supported by the European Commission Andrea Micheli 1, Paolo Baili 1, Carmen Martinez 2,
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Breast Cancer - UK December 2011 For more information.
DIABOLO has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No Project duration:
Information network on rare cancers RARECARENet Annalisa Trama, Gemma Gatta Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)
EU Public Health Programme Strand 1: Improve information system Establish Working Parties: 1.Lifestyle and other health determinants 2.Morbidity.
1 EUROPA DONNA – The European Breast Cancer Coalition Susan Knox, Executive Director KEEPING BREAST CANCER ON THE EUROPEAN HEALTH AGENDA.
RARECARE project Cancer registries and rare cancers: quality of data, supplementary information RARECARE WP6, 3 rd meeting th National Institute of Public.
High Resolution Studies within the European Cancer Information System Cooperation with EPAAC Riccardo Capocaccia Istituto Superiore di Sanità (ISS), Italy.
NOT ALL PAST SUCCESSES IN CANCER RESEARCH HAVE BEEN FOLLOWED BY ACTIONS EUROCHIP-2 THE ACTION Project & news EUROCHIP-2 THE ACTION Project & news Public.
Work Package 5 Information on centres of expertise for rare cancers WP leader: Sabine Siesling.
Objectives of Work Package 5 objectives for today Information on centres of expertise for rare cancers WP leader: Sabine Siesling.
DISCUSSION. EUROCHIP-2 ACTION PLAN COUNTRY 1COUNTRY 2COUNTRY 3 COUNTRY 30 ACTION1ACTION1 ACTION2ACTION2 ACTION3ACTION3 ACTION3ACTION3 ACTION4ACTION4 ACTION4ACTION4.
Modernising Cancer Services Some Thoughts from Western Europe Jean Mossman February 2013.
Information network on rare cancers RARECARENet Annalisa Trama, Gemma Gatta Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)
1 "Cancer and the European Citizen – it’s time to deliver! Francesco De Lorenzo ECPC President ECPC Members in Action Conference 2009 ALL CANCER PATIENTS.
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
Information network on rare cancers INFORMATION NETWORK ON RARE CANCERS (RARECARENet) Kick-off meeting - Friday, July Gemma Gatta Fondazione IRCCS,
EUROCHIP-2 EUROCHIP-2 - The Action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.
RARECARE project Data quality and supplementary information Granada, March 25 th 2009 Andalusian School of Public Health.
European Union against cancer The EUROCHIP project 1st International Cancer Control Congress Vancouver, October 2005 Public Health Program EUROPEAN.
© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Colorectal Cancer - UK December 2011 For more information.
Information network on rare cancers Work Package 4 Information on epidemiology of rare cancers Riccardo Capocaccia and Sandra Mallone Cancer Epidemiology.
EUROCHIP-Italia in EUROCHIP-2 Health Indicators for Monitoring Cancer in Europe Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION.
Third Meeting of the Generations and Gender Programme Informal Working Group Spetses, Greece, May 2004.
Dr Andrea Micheli Descriptive Epidemiology and Health Planning Unit Fondazione IRCCS “Istituto Nazionale dei Tumori” Milan Public Health Programme EUROPEAN.
ICE Collaboration with EU Anne Mette T. Johansen & Birthe Frimodt-Møller Denmark International Collaborative Effort on Injury Statistics May.
Cancer inequalities in Europe UKACR & NCIN Conference, 17/18 June 2010 Dr. Andrea Micheli Director Descriptive Study and Health Planning Unit Fondazione.
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
Early DETECTion and integrated management of TuBerculosis in europe: E-DETECT TB Professor Ibrahim Abubakar Director, Institute for Global Health University.
Scottish Renal Cancer Forum National Meeting 31st March 2016 Renal cancer survival Period of diagnosis: Roger Black.
Research using Registries
Italy - Evidence package
Romanian Rare Cancers Association – RCArare Darkó Emese
Musculoskeletal Health in Europe
WP 4 – EPIDEMIOLOGY GEMMA Gatta
A&M Workplan Objectives
DIABOLO has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No Project duration:
Davor Kozmus, MHEST Steering Platform Meeting 29. October 2009, Zagreb
HEDIC Health expenditures by diseases and conditions
Testicular Cancer (C62): 2008 Estimates
Working Package 7 (WP7) Health Care
SOCIAL DIALOGUE WITHIN THE SCOPE OF EUPAN
Item 4.3 Gender statistics
Maternal and newborn health in Europe: surveillance and research
Eurostat contribution
General Assembly, 26th October, 2018, Milan
WP 10 National Cancer Plans Prepared by:
EUROPEAN PARTNERSHIP FOR ACTION AGAINST CANCER
Josep M. Borras Milano, October 25, 2018
Aurora Hoxha & Drini Imami
Presentation transcript:

STEERING COMMITTEE MEETING EUROPEAN PARTNERSHIP:ACTION AGAINST CANCER (EPAAC) Bruxelles 8th December 2010 WP 9  HEALTH INFORMATION AND THE COLLECTION AND ANALYSIS OF COMPARABLE DATA Milena Sant WP9 leader, INT Milan, Italy

Aims of WP 9 To map the main sources of cancer data in Europe and to identify the priority topics to be supported by the Partnership. To unify under a common platform cancer burden indicators (incidence, mortality, survival and prevalence) provided by existing European activities. To promote a European task force aimed to discuss the need for data on cancer costs and to produce an inventory of relevant available information. To initiate a development of a standardised approach to the routine collection of data on survivorship using population based cancer registries. To develop an inventory of statistical methods to analyse population based cancer data. Bruxelles 8/12/2010

Aims of WP 9 To map the main sources of cancer data in Europe and to identify the priority topics to be supported by the Partnership. To unify under a common platform cancer burden indicators (incidence, mortality, survival and prevalence) provided by existing European activities. To promote a European task force aimed to discuss the need for data on cancer costs and to produce an inventory of relevant available information. To initiate a development of a standardised approach to the routine collection of data on survivorship using population based cancer registries. To develop an inventory of statistical methods to analyse population based cancer data. Bruxelles 8/12/2010

Cancer Institutes clinical data bases EXISING DATA SOURCES: Cancer registries Statistical Institutes (population structure by age, sex and geographical area, population projections in the future, mortality). Administrative sources: density of general and specialized doctors, density of imaging machines, number of radiotherapy units, etc), drugs and other resources provided for cancer care. Cancer Institutes clinical data bases A European map of cancer information will be built, using the indicators identified by EUROCHIP and ECHI. The map will identify areas of data availability and data needs. Focal point: INT ACC (AP):organisation of final meeting to provide recommendations for the next programme of EC action (2014-2020) in the field of Cancer Information Bruxelles 8/12/2010

Aims of WP 9 To map the main sources of cancer data in Europe and to identify the priority topics to be supported by the Partnership. To unify under a common platform cancer burden indicators (incidence, mortality, survival and prevalence) provided by existing European activities. To promote a European task force aimed to discuss the need for data on cancer costs and to produce an inventory of relevant available information. To initiate a development of a standardised approach to the routine collection of data on survivorship using population based cancer registries. To develop an inventory of statistical methods to analyse population based cancer data. Bruxelles 8/12/2010

EXISTING CANCER INFORMATION Incidence from population-based cancer registries centralized and regularly published by IARC. Survival collected and centralized by the EUROCARE network and related projects (HAEMACARE, RARECARE). Prevalence most recent European comparative and observation-based data are those pertaining to 1992, provided by the EUROPREVAL project. Mortality collected at the national level by official death certificates. Cancer mortality statistics by country and registry area are organized and diffused by IARC. High Resolution studies with detailed clinical information collected by cancer registries (France, Italy, Spain, UK), centralised by EUROCARE Bruxelles 8/12/2010

Task delivered by IARC, ENCR WP9 will bring together all the existing partners working at the pan-European level on cancer burden indicators Provision of updated incidence and mortality data (including data from HAEMACARE and RARECARE) Task delivered by IARC, ENCR Population survival, and sample high resolution data on stage and treatment from cancer registries. Focal point: INT, ISS (through EUROCARE) Prevalence will be provided mainly from EUROPREVAL. Focal point: INT, ISS, in collaboration with IARC Bruxelles 8/12/2010

Aims of WP 9 To map the main sources of cancer data in Europe and to identify the priority topics to be supported by the Partnership. To unify under a common platform cancer burden indicators (incidence, mortality, survival and prevalence) provided by existing European activities. To promote a European task force aimed to discuss the need for data on cancer costs and to produce an inventory of relevant available information. To initiate a development of a standardised approach to the routine collection of data on survivorship using population based cancer registries. To develop an inventory of statistical methods to analyse population based cancer data. Bruxelles 8/12/2010

- Constitution of a task force of experts, epidemiologists, health planners, economist and stakeholders, to reach consensus on common methodology to collect cancer cost data. - inventory of population based studies on cancer costs - discussion on best methodology to collect comparable data on cancer costs at population level - regression analysis between socioeconomic indicators and cancer outcomes to study correlation between economy and cancer outcomes; - discussion on deprivation index to estimate cancer survival by social class. Focal point: INT AP: INT, INSERM, INRC Collaboration with OECI, FAVO, OECD and IARC. Bruxelles 8/12/2010

Aims of WP 9 To map the main sources of cancer data in Europe and to identify the priority topics to be supported by the Partnership. To unify under a common platform cancer burden indicators (incidence, mortality, survival and prevalence) provided by existing European activities. To promote a European task force aimed to discuss the need for data on cancer costs and to produce an inventory of relevant available information. To initiate a development of a standardised approach to the routine collection of data on survivorship using population based cancer registries. To develop an inventory of statistical methods to analyse population based cancer data. Bruxelles 8/12/2010

ability to get health care and follow up treatment, SURVIVORSHIP physical, psychosocial, and economic issues of cancer, from diagnosis until the end of life, beyond the acute diagnosis and treatment phase quality of life of cancer survivors, including social, familiar, sexual and emotional aspects. ability to get health care and follow up treatment, late effects of treatment. A standardised approach to the routine collection of survivorship data using population based cancer registries in various European countries will be studied Focal point: INT, in collaboration with IARC, patients’ organizations (FAVO, ECPC), international and national networks (OECI, ACC) and stakeholders. Bruxelles 8/12/2010

Aims of WP 9 To map the main sources of cancer data in Europe and to identify the priority topics to be supported by the Partnership. To unify under a common platform cancer burden indicators (incidence, mortality, survival and prevalence) provided by existing European activities. To promote a European task force aimed to discuss the need for data on cancer costs and to produce an inventory of relevant available information. To initiate a development of a standardised approach to the routine collection of data on survivorship using population based cancer registries. To develop an inventory of statistical methods to analyse population based cancer data. Bruxelles 8/12/2010

POPULATION BASED STATISTICAL ANALYSIS: trend and projections analysis, national estimates of incidence in countries with limited registry coverage, survival analysis, prevalence estimates, cross- analysis between incidence and survival indicators and Health Care System and socio-economic indicators. A European network on data analysis will allow to start building a European capacity for statistical analysis, projections and forecasting epidemiological cancer indicators A panel of experts in population based data analyses, projections and forecasting will be identified by ISS and IARC in consultation with ENCR and other subjects. Focal point: ISS, in collaboration with with ENCR, FRANCIM, IARC, IKNE, INT Bruxelles 8/12/2010

WP 9 PLANNED ACTIVITIES FOR 2011 Meetings/Working groups between ENCR, EUROCOURSE, EUROCARE members to revise the availability of incidence, survival, survivorship, prevalence and mortality data and to discuss a common platform to make available these indicators Revision of available data on population data patterns of care at European level. Production of draft protocol for unifying data collection on patterns of cancer care in Europe Meeting with experts in population based statistical analysis Preparation of the prototype of a common website with all cancer indicators available in EU Production of updated cancer survival data for patients diagnosed after 2000 in Europe (EUROCARE-5) Bruxelles 8/12/2010

WP 9 PLANNED ACTIVITIES FOR 2011 Cancer costs March 2011: meeting with OECD in order to individuate experts across Europe and possibility to contact them through OECD Revision of existing data/databases on Cancer cost Cancer across Europe Meetings/Working groups focussed on methods to estimate population based cancer costs May 2011: meeting with INRC (Genoa Institute) to organize the collection of data for regression analysis between socioeconomic variables (at cancer registry level) and survival June 2011: meeting (or conference call) with ERI3 INSERM (France institute) in order to discuss activity on deprivation indexes and their comparability across countries Bruxelles 8/12/2010

WP-9 ASSOCIATED PARTNERS INT – Fondazione IRCCS “Istituto Nazionale Tumori” – Milano - Italy ISS – Istituto Superiore di Sanità – Italy - Rome INRC – Istituto Nazionale Ricerca sul Cancro – Genoa - Italy ERI3 INSERM – France IKNO – Integraal Kankercentrum Noord-Oost - The Netherlands IOL – Institute of Oncology Ljubljana - Slovenia Bruxelles 8/12/2010